IL6 and gastric adenocarcinoma: We first compared the IL-6 mRNA expression in publicly available datasets from healthy stomach samples (n=174, GTEx) and tumor samples (n=414, TCGA-stomach adenocarcinoma) and showed that IL-6 expression was significantly enhanced in tumor tissues (P ≤ 0.0001) (Fig. 1A).